We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+261.51%
AUM
$798M
AUM Growth
+$4.7M
Cap. Flow
+$15.9M
Cap. Flow %
1.99%
Top 10 Hldgs %
28.26%
Holding
1,061
New
107
Increased
339
Reduced
142
Closed
61

Top Buys

Rank Stock Value
1
NEE icon
NextEra Energy
NEE
+$9.24M
2
CMS icon
CMS Energy
CMS
+$6.94M
3
MDT icon
Medtronic
MDT
+$5.04M
4
CI icon
Cigna
CI
+$5M
5
VZ icon
Verizon
VZ
+$2.79M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$11.5M
2
BAX icon
Baxter International
BAX
+$7.06M
3
ED icon
Consolidated Edison
ED
+$5.73M
4
BDX icon
Becton Dickinson
BDX
+$4.91M
5
SCHW
Charles Schwab
SCHW
+$3.65M

Sector Composition

Rank Sector Weight
1 Financials 16.87%
2 Technology 13.49%
3 Healthcare 9.73%
4 Consumer Staples 7.96%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSTA icon
451
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$15K ﹤0.01%
+348
New +$15K
HCA icon
452
HCA Healthcare
HCA
$88.5B
$15K ﹤0.01%
63
– –
HSIC icon
453
Henry Schein
HSIC
$9.83B
$15K ﹤0.01%
200
– –
MAR icon
454
Marriott International
MAR
$93.8B
$15K ﹤0.01%
100
– –
SLB icon
455
SLB Ltd
SLB
$76.5B
$15K ﹤0.01%
511
– –
VTRS icon
456
Viatris
VTRS
$19B
$15K ﹤0.01%
1,135
-60
-5% -$851
AYX
457
DELISTED
Alteryx Inc
AYX
$15K ﹤0.01%
+200
New +$15.1K
BSX icon
458
Boston Scientific
BSX
$71.4B
$14K ﹤0.01%
322
+45
+16% +$1.99K
EQT icon
459
EQT Corp
EQT
$32.3B
$14K ﹤0.01%
689
+189
+38% +$3.66K
KODK icon
460
Kodak
KODK
$925M
$14K ﹤0.01%
2,000
– –
NKE icon
461
Nike
NKE
$62.3B
$14K ﹤0.01%
95
– –
RPM icon
462
RPM International
RPM
$14.8B
$14K ﹤0.01%
180
– –
SPR
463
DELISTED
Spirit AeroSystems
SPR
$14K ﹤0.01%
315
– –
UBS icon
464
UBS Group
UBS
$173B
$14K ﹤0.01%
885
– –
ZWS icon
465
Zurn Elkay Water Solutions
ZWS
$8.6B
$14K ﹤0.01%
436
+62
+17% +$1.74K
CPAY icon
466
Corpay
CPAY
$26B
$14K ﹤0.01%
53
+14
+36% +$3.62K
TTOO
467
DELISTED
T2 Biosystems, Inc
TTOO
$14K ﹤0.01%
3
– –
SCU
468
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$14K ﹤0.01%
+516
New +$13.4K
BXP icon
469
Boston Properties
BXP
$11B
$13K ﹤0.01%
120
– –
CX icon
470
Cemex
CX
$16.3B
$13K ﹤0.01%
1,768
– –
DD icon
471
DuPont de Nemours
DD
$19.5B
$13K ﹤0.01%
154
+23
+18% +$2.13K
DOC icon
472
Healthpeak Properties
DOC
$14.5B
$13K ﹤0.01%
381
– –
NOC icon
473
Northrop Grumman
NOC
$80.7B
$13K ﹤0.01%
35
– –
OXY icon
474
Occidental Petroleum
OXY
$55.7B
$13K ﹤0.01%
434
-208
-32% -$5.55K
PGR icon
475
Progressive
PGR
$125B
$13K ﹤0.01%
149
– –
17 18
19
20 21

Similar funds

SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
AF
Atlas FRM Greenwich, Connecticut $1.53B AUM 14.94% 1-Year Est. Return
ACL
Azora Capital LP Miami, Florida $1.52B AUM 39.16% 1-Year Est. Return
KCM
Knighthead Capital Management New York $1.52B AUM 19.8% 1-Year Est. Return

Howe & Rusling's Q3 2021 Portfolio in Review

As of Q3 2021, Howe & Rusling held 1,061 positions worth $798M, up 0.59% from $793M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Howe & Rusling's Q3 2021 filing shows 107 new, 339 increased, 142 reduced and 61 closed positions. Its largest new stake was CMS Energy: 111,259 shares worth $6.65M. The largest sale was Pfizer, an estimated $11.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Howe & Rusling's largest Q3 2021 buy was CMS Energy: 111,259 shares worth $6.65M.
  • Howe & Rusling added most to NextEra Energy in Q3 2021, an estimated $9.24M increase.
  • Howe & Rusling's biggest Q3 2021 reduction was Pfizer, cutting an estimated $11.5M.
  • Howe & Rusling fully exited Frontdoor in Q3 2021, selling an estimated $154K.
  • Howe & Rusling's ten largest holdings make up 28% of its $798M portfolio in Q3 2021.
  • Howe & Rusling opened 107 new positions and closed 61 in Q3 2021.
  • Howe & Rusling's portfolio value rose 0.59% quarter-over-quarter to $798M.

Based on Howe & Rusling's 13F filing for Q3 2021, filed 15 Nov 2021.